Cysteamine Hydrochloride is the salt formulation of the decarboxylated form of the amino acid cysteine. Clinically, cysteamine hydrochloride is used in the treatment of radiation sickness and disorders of cysteine excretion. Cysteamine cleaves the disulfide bond with cystine to produce molecules that can escape the metabolic defect in cystinosis and cystinuria. It is believed to inhibit DMBA-induced tumors.

Market Analysis and Insights: Global Cysteamine Hydrochloride Market
The global Cysteamine Hydrochloride market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cysteamine Hydrochloride Scope and Market Size
The global Cysteamine Hydrochloride market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cysteamine Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
≤95％
＞95%

Segment by Application
Pharmaceutical
Pesticide
Cosmetic
Feed Additives
Other

The Cysteamine Hydrochloride market is analysed and market size information is provided by regions (countries). Segment by Application, the Cysteamine Hydrochloride market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
CarboMer
Zhonglan Industry
Shanghai FIT Group
Hangzhou King Techina Technology
Discovery Fine Chemicals Limited
Yixing Yirun Biotechnology